Published in Gene Therapy Weekly, March 3rd, 2005
"This is going to potentially change the face of the No. 1 cause of death and disability," said Eric Topol, MD, the Clinic's chief academic officer and chairman of its department of cardiovascular medicine.
Topol will coordinate the study of the genes that lead to heart attacks and atherosclerosis, the process by which fatty deposits build up on the inner lining of an artery and create plaques.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.